Hemodynamic and biochemical effects of a new positive inotropic agent. Antibiotic ionophore RO 2-2985.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002264:Carboxylic Acids / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles; D006439:Hemodynamics / Q000187:drug effects*; D007474:Ion Exchange; D009130:Muscle, Smooth / Q000187:drug effects; D011188:Potassium; D012110:Reserpine / Q000008:administration & dosage; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D012964:Sodium; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D012110:Reserpine; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium; D002118:Calcium